Dahlén SE and Kumlin M |
Monitoring mast cell activation by prostaglandin D2 in vivo. |
2004 |
Thorax |
pmid:15170020
|
Bochenek G et al. |
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. |
2004 |
Thorax |
pmid:15170023
|
O'Sullivan S et al. |
Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine. |
1998 |
Thorax |
pmid:10195076
|
Xie S et al. |
15 deoxy delta12,14 PGJ2 induces procoagulant activity in cultured human endothelial cells. |
2002 |
Thromb. Haemost. |
pmid:11916086
|
Inoue T et al. |
Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. |
2001 |
Thromb. Haemost. |
pmid:11204569
|
Hardy E et al. |
Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP. |
1995 |
Thromb. Haemost. |
pmid:8560425
|
Eligini S et al. |
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. |
2002 |
Thromb. Haemost. |
pmid:12353085
|
Bertelé V et al. |
SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. |
1984 |
Thromb. Haemost. |
pmid:6326343
|
Artwohl M et al. |
Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells. |
2005 |
Thromb. Haemost. |
pmid:15886792
|
Blockmans D et al. |
Heparin-induced thrombocytopenia platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities. |
1986 |
Thromb. Haemost. |
pmid:3518134
|
Orchard MA et al. |
Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. |
1985 |
Thromb. Res. |
pmid:3936223
|
Chou TC and Li CY |
Inhibitory mechanisms of dantrolene on platelet aggregation. |
1999 |
Thromb. Res. |
pmid:10593433
|
Lin CH et al. |
HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. |
1992 |
Thromb. Res. |
pmid:1412184
|
Ide T et al. |
Activation of nuclear receptors by prostaglandins. |
2003 |
Thromb. Res. |
pmid:14592554
|
Chen WY et al. |
The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation. |
1994 |
Thromb. Res. |
pmid:8073410
|
Fortini A et al. |
Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. |
1985 |
Thromb. Res. |
pmid:3001968
|
Kanehara H et al. |
Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazone. |
2002 |
Thromb. Res. |
pmid:12617986
|
Kumagai M et al. |
15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. |
2004 |
Tohoku J. Exp. Med. |
pmid:14998300
|
Nakazawa I et al. |
Some features in prostaglandin synthesis of the cancer cells which metastasized into liver from intestinal cancer lesions. |
1993 |
Tohoku J. Exp. Med. |
pmid:8266326
|
Takeda K et al. |
Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker. |
2007 |
Tohoku J. Exp. Med. |
pmid:17347546
|